Recommendations for the ongoing Trilogues on the revision of the EU pharmaceutical legislation

The European Patients’ Forum (EPF) has released its recommendations for the ongoing Trilogues on the revision of the EU pharmaceutical legislation. As the EU institutions engage in trilateral discussions, it is crucial for EPF to convey the patient voice and re-state our key priorities.  

This revision is a once in a generation opportunity to update the current regulatory framework for medicinal products and ensure it responds to current public health challenges, from antimicrobial resistance to medicines shortages and crisis preparedness. In addition, it reflects the pressing need for stronger EU action to address growing inequalities in access to medicines across EU member states. It should also provide a strengthened framework for patient engagement in regulatory processes, reflecting over 20 years of EMA engagement and progress in this area. 

Ultimately, as the revision transforms the regulatory environment in the EU, it is crucial to ensure it meets the needs of those who rely on safe, effective, and high-quality medicines: the patients.

Read EPF's position here.